Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds

The antiviral drug ensitrelvir prevents infection in household contacts of COVID-19 patients when given within 72 hours after symptom onset in the index patient, according to a Phase III randomized controlled trial published in the New England Journal of Medicine.